AORT Artivion Inc

  1. Stocks
  2. Healthcare
  3. NYSE: AORT

Price (delayed)

$28.41

Market cap

$1.39B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.05

Enterprise value

$1.72B

?
Relative Growth: Rel. Growth: 54
Relative Strength: Rel. Strength: 25
Relative Valuation: Rel. Valuation: 21
Relative Profitability: Rel. Profitability: 57

Headquartered in suburban Atlanta, Georgia, Artivion, Inc., is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients ...

Highlights
Artivion's gross profit has increased by 17% YoY and by 2.5% QoQ
The company's revenue rose by 16% YoY and by 2.8% QoQ
The net income has plunged by 127% from the previous quarter but it has soared by 82% YoY
Artivion's EPS has shrunk by 119% QoQ but it has surged by 88% YoY
AORT's debt has soared by 58% since the previous quarter and by 55% year-on-year
AORT's quick ratio is down by 24% year-on-year
Sector: Healthcare
Industry: Medical Devices
Website: http://www.cryolife.com
Peers: ABT MDT SYK BSX

Key stats

What are the main financial stats of AORT

AORT stock price

How has the Artivion stock price performed over time
Intraday
-0.8%
1 week
6.93%
1 month
18.23%
1 year
-35.03%
YTD
-37.71%
QTD
26.44%

Financial performance

How have Artivion's revenue and profit performed over time
Revenue
$471.47M
Gross profit
$303.5M
Operating income
$13.64M
Net income
-$3.17M
Gross margin
64.4%
Net margin
-0.7%
AORT's net margin has dropped by 128% since the previous quarter but it has soared by 84% year-on-year
The net income has plunged by 127% from the previous quarter but it has soared by 82% YoY
The operating margin has dropped by 56% since the previous quarter and by 33% year-on-year
The company's operating income has shrunk by 55% QoQ and by 22% YoY

Price vs fundamentals

How does AORT's price correlate with its fundamentals

Growth

What is Artivion's growth rate over time

Valuation

What is Artivion stock price valuation
P/E
N/A
P/B
3.1
P/S
2.92
EV/EBIT
64.74
EV/EBITDA
30.46
EV/Sales
3.64
Artivion's EPS has shrunk by 119% QoQ but it has surged by 88% YoY
The stock's price to book (P/B) is 21% less than its last 4 quarters average of 3.9
Artivion's equity has increased by 6% YoY
The price to sales (P/S) is 25% lower than the last 4 quarters average of 3.9 but 8% higher than the 5-year quarterly average of 2.7
The company's revenue rose by 16% YoY and by 2.8% QoQ

Efficiency

How efficient is Artivion business performance
AORT's ROE has shrunk by 126% QoQ but it has soared by 87% YoY
AORT's return on assets has dropped by 123% since the previous quarter but it has surged by 86% year-on-year
The ROIC has soared by 63% YoY but it is down by 40% QoQ
Artivion's return on sales has increased by 40% YoY but it has decreased by 38% QoQ

Dividends

What is AORT's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history

Special dividends are included in TTM DPS and yield

Financial health

How did Artivion financials performed over time
The total assets is 71% greater than the total liabilities
The total liabilities has grown by 50% year-on-year and by 45% since the previous quarter
The total assets has increased by 28% year-on-year and by 21% since the previous quarter
AORT's debt is 8% smaller than its equity
The debt to equity has soared by 61% from the previous quarter and by 46% YoY
AORT's debt has soared by 58% since the previous quarter and by 55% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.